{"name":"Zhenzhen Liu","slug":"zhenzhen-liu","ticker":"","exchange":"","domain":"","description":"Zhenzhen Liu is a biotechnology company focused on developing innovative cancer treatments, with a pipeline that includes two phase 2 drug regimens.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBlMnVnYW43MXdkWlZqYVpYMlFaYTZXVktrcUE1S2t5anptVzNGQll0M3RWNk90SG42ZmZLV3E4SEZTVEpmblJON2g4cDF0RnFzN09ZTVhNdEw0RG01RXRnRzJSQVlkbFdIWldndHpzR2U?oc=5","date":"2023-11-30","type":"pipeline","source":"Wiley Online Library","summary":"Synthesis and activity of arylcoumarin derivatives with therapeutic effects on diabetic nephropathy - Wiley Online Library","headline":"Synthesis and activity of arylcoumarin derivatives with therapeutic effects on diabetic nephropathy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPaW9ncmh2S243UHdtZDdJTW9LMVlCc24tUW5nZVFzNzNFaF9kSWVWRG0tNTRHSEUxdW5meVdWTWdfSHJhS2ZmbUh2eUJhMEVOQnNzQlBiNnpwMy1CUEpmZ1k4VVdMY0p5UWJfTFNlcjFtOWZsdWpyVXprQzlEZENaLWlLMk5HUHM5?oc=5","date":"2023-09-29","type":"pipeline","source":"ScienceDirect.com","summary":"Acta Pharmaceutica Sinica B | Vol 13, Issue 10, Pages 3963-4340 (October 2023) - ScienceDirect.com","headline":"Acta Pharmaceutica Sinica B | Vol 13, Issue 10, Pages 3963-4340 (October 2023)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9BM0swSWFmUVBhQkVTWWwwcTd5Mnc4RXNEMTF2VmlRMUhsTFRBbVY1OXctWXlHUUY5TDZOT0lOcVp0YngtaHFkbkxTd1BjbEpEcXNZSHFxU1ppaS00SzV3RTFXNWx4dnREU0h3cldlVG5pejFpX1A2akJhTQ?oc=5","date":"2023-09-15","type":"pipeline","source":"ScienceDirect.com","summary":"Recent advances on mulberry volatile flavor: A review - ScienceDirect.com","headline":"Recent advances on mulberry volatile flavor: A review","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-12-09","type":"pipeline","source":"South China Morning Post","summary":"China targets online pharmacies for price gouging on Covid-19 medication - South China Morning Post","headline":"China targets online pharmacies for price gouging on Covid-19 medication","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}